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Abstract

Objective: The aim of this study was to examine rates of psychotropic medication use over time among a national probability
sample of youths involved with child welfare=child protective services (CW=CPS) in the National Survey of Child and
Adolescent Well-Being (NSCAW).
Methods: Growth mixture modeling was used to classify 2,521 youths into groups based on individual medication use
trajectories. Determinants associated with groupings were examined using logistic regression.
Results: Overall, 22% of youths used medications over 3 years. Three groups were identified: (1) Low medication use (85%,
n ¼ 2,057), where medication was used rarely or never; (2) increasing medication use, where medication was commonly
started after investigation (4%, n ¼ 148); and (3) high medication use, where medication use was endorsed over multiple study
waves (12%, n ¼ 316). On multivariate modeling, physical abuse predicted membership in the increasing-use group (reference group, low use); Caucasian (versus African American) and need predicted membership in the high-use group (reference
group, low use). Male gender was associated with membership in both the increasing-use and high-use groups (reference
group, low use). Age and abuse type (physical abuse, neglect) demonstrated complex relationships with group membership.
Conclusions: Psychotropic medication use trajectories for children in child welfare vary and are best understood when
disaggregated into distinct subpopulations.

Introduction

Y

ouths involved with the child welfare=child protective
services system (CW=CPS) represent a uniquely vulnerable
subpopulation of U.S. youths. Their numbers are staggering: In
2006, caregivers of approximately 6.0 million youths were reported
for abuse or neglect and roughly 510,000 youths were living in outof-home care on any given day (U.S. Department of Health and
Human Services, Administration for Children, Youth and Families
2008a; U.S. Department of Health and Human Services, Administration for Children, Youth and Families 2008b). These youths
share histories characterized by abuse, neglect, domestic violence,
poverty, and in utero and environmental drug exposure. Research
has confirmed the negative impact of these risk factors; high rates of
behavioral problems have consistently been documented among
youths investigated by CW=CPS, whether or not they are removed
from their home and placed into out-of-home care or remain in the
care of their parents (Simms and Halfon 1994; Pilowsky 1995;
Clausen et al. 1998; Landsverk et al. 2002; Burns et al. 2004).

A relatively large body of research now exists describing outpatient mental health services use by youths investigated by
CW=CPS. Most of the recent data come from the National Study of
Child and Adolescent Well-Being (NSCAW), a longitudinal, national probability cohort of over 5,500 youths undergoing investigation for alleged abuse and=or neglect (Dowd et al. 2004). These
data indicate that outpatient mental health services use among
youths in CW=CPS reflect the presence of clinically significant
behavioral problems as well as moderating factors, such as age,
race=ethnicity, and maltreatment history (Burns et al. 2004).
In contrast to the numbers of studies describing service use, there
is a relative dearth of data regarding psychotropic medication use.
The few regional studies available show rates of medication use
ranging from 13% to 37%, (Zima et al. 1999a; Zima et al. 1999b;
Breland-Noble et al. 2004; McMillen et al. 2004; Raghavan et al.
2005; Ferguson et al. 2006; Zito et al. 2008) compared with approximately 4% in youths in the general population (Olfson et al.
2002). One national study, using data from NSCAW, estimated that
approximately 14% of youths were using psychotropic medications
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approximately 12 months following investigation. Age, gender,
Caucasian race=ethnicity, history of physical abuse, public insurance, and borderline=clinical cutoff scores on the Child Behavior
Checklist were associated with higher proportions of medication
use (Raghavan et al. 2005). All of these studies to date have been
cross sectional in nature and have not examined rates of psychotropic medication use over time.
It is important to increase our knowledge regarding rates of
longitudinal medication use given the responsibility placed on child
welfare agencies and Medicaid to provide ongoing oversight and
coordination of mental health services, including medication, for
children removed from their homes under recently passed federal
legislation, ‘‘Fostering Connections to Success and Increasing
Adoptions Act’’ (P.L. 110–351) (United States 110th Congress
2008). Previous research using NSCAW indicates that outpatient
mental health service use varies over time, with a rapid increase in
outpatient use documented for all youths following investigation,
but particularly for youths placed in out-of-home care, even when
controlling for behavior problems (Leslie et al. 2005). If outpatient
services vary in relation to a CW=CPS investigation, it is possible
that rates of psychotropic medication use show a similar pattern and
increase substantively following investigation.
On the basis of these previous findings, we hypothesized that a
signification proportion of youths would show an increase in
medication use following investigation. Growth mixture modeling
(GMM) uses sophisticated statistical techniques to identify unobserved subpopulations within a larger population group, taking into
account the nesting of time observations within individuals (Muthén and Muthén 2000; Muthén 2002). Thus, in this research, we
analyzed data from the NSCAW sample with the following aims:
(1) To identify distinct, heterogeneous groups of youths based on
individual longitudinal trajectories of psychotropic medication use,
and (2) to determine the impact of the child’s sociodemography,
maltreatment history, and behavioral problems on membership
within these groups.
Methods
Overview
The NSCAW study tracked a cohort of 5,501 U.S. children, aged
birth to 16 years at enumeration. The study was funded by the
Federal Administration on Children and Families, and data collection was completed by the Research Triangle Institute (RTI).
RTI employed a two-stage, stratified-sample design. First, RTI
selected primary sampling units (PSUs) defined as geographic areas
that encompassed the population served by a single CW=CPS
agency and tended to represent single counties. Of the 100 selected
PSUs, seven were small and were combined with adjacent counties,
and eight had legislation in place limiting their participation. The
final sample comprised 92 PSUs, representing 97 counties. The
second-stage sampling identified 5,504 index children from lists of
children undergoing investigation from October, 1999, through
December, 2000, in PSUs. The framework oversampled for certain
subsets within CW=CPS, such as infants, sexually abused children,
and children receiving CW=CPS services. Approval for this study
was given by the U.S. Office of Management and Budget and the
Institutional Review Boards (IRB) of RTI, University of North
Carolina, Rady Children’s Hospital–San Diego, Tufts Medical
Center, and state or county IRBs representing communities involved with the study. Face-to-face informed consent was obtained
by trained field representatives. For these analyses, we selected a
subsample of children ages 2 years and greater at wave 1.
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Procedure
Interviews were conducted with youths (where age appropriate),
their caregivers, and their CW=CPS workers at wave 1 (baseline)
and at three follow-up intervals (12-month, 18-month, and 36month waves). Wave 1 interviews with child welfare workers were
completed on average 5.2 months after investigation (standard
deviation [SD] ¼ 2.8 months) and with caregivers 5.6 months after
(SD ¼ 2.8 months). Wave 2, 3, and 4 follow-up interviews with
caregivers were conducted on average at 13.9 (SD ¼ 2.9), 21.0
(SD ¼ 3.0), and 36.9 (SD ¼ 2.9) months, respectively. At each
wave, respondents were asked whether the index child was currently using medications for emotional, behavioral, learning, attentional, or substance abuse problems as well as using general
medical, outpatient specialty mental health services, and services in
restrictive settings (e.g., day treatment, residential care, inpatient
setting) for these types of problems. Attrition was limited; 71% of
cases were missing zero to one interviews across all child, caregiver, and caseworker interviews.
Measures
Table 1 describes all variables and pertinent references. Child
demographics examined included youth age, gender, and
race=ethnicity. We also included maltreatment history at baseline
as a series of indicator variables, given the overlap in types of
maltreatment experienced by youths. Youths were considered in
need of mental health services if they scored in the clinical range
(64 or above) on the internalizing, externalizing, or total problem
subscales of the Parent Version of the Child Behavior Checklist
(CBCL) and=or the Youth Self-Report (YSR) for youths 11 years
of age (Achenbach 1991; Achenbach 1992; Achenbach 1997). The
clinical cutoff point, rather than the borderline range, was used to
avoid inflating our estimate of need. The use of the CBCL as a
proxy for need for clinical services has been employed in multiple
mental health services research studies in the past (McIntyre and
Keesler 1986; Clausen et al. 1998; James et al. 2004). We included
insurance status as a control variable, given this may act to either
facilitate or hinder medication use. Finally, we included three
control variables (use of general medical services, use of outpatient
mental health services, and use of restrictive care [e.g., group home,
residential] services) to control for access to services and allow us
to better understand the impact of the primary variables in the
model. This approach has been previously used by other researchers examining mental health service use (Zima et al. 1999a;
Raghavan et al. 2006; Horwitz et al., in press ). Our primary outcome measure was groups of children derived using GMM based on
medication use patterns over the four study waves (Wang and
Bodner 2007).
Data analysis
We employed GMM to identify distinct, heterogeneous groups
of children with varied medication use trajectories over time using
M-Plus, (Muthén and Muthén 2007), a statistical software package
well equipped to handle the complex issues that arise when analyzing growth curves. Missing data patterns were evaluated and
treated with full information maximum likelihood estimation for
missing values, capitalizing on all available data. After deriving the
groups, we employed chi-squared analyses and multivariate logistic regression, using SUDAAN version 10 (Research Triangle
Institute 2008), to estimate the associations between independent
variables and group membership. Both logistic and polychotomous
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Table 1. Outcome and Independent Variables in the NSCAW Study Used in This Research
Measure if
applicable

Wave

Categorical variable measured at each wave
regarding medication use for
emotional=behavioral=learning=attentional
or substance use problems.
Variable derived regarding medication use
patterns (low use, high use; increasing use).

NA

1, 2, 3, 4

NA

NA

Placement in out-of-home care at wave 1 (i.e.,
kinship care, non-relative foster care, group
home, residential care, other unspecified)
versus in-home
Demographics
Child’s age, gender, race=ethnicity
Maltreatment
Indicator variables for the presence or absence
history
of four different types of abuse: (1) Physical
abuse, (2) sexual abuse, (3) physical or
supervisory neglect, (4) abandonment.
Emotional and
Dichotomous variable indicative of a
behavior
Externalizing, Internalizing, or Total
problems
Problem score on the CBCL or the YSR at
or above the clinical cut point of T ¼ 64;
available for ages 2þ in NSCAW. Two
forms of the CBCL were used: One for
children aged 2–3 years and another for
children aged 4–18 years.
Child’s insurance
Categorical variable: (1) Medicaid,
status
(2) private=Champus, (3) uninsured.
General medical use Any general medical service for an emotional,
behavioral, learning, attentional, or
substance use problem. Referent time
period was over the 3 years of the study for
temporary caregivers and lifetime for
permanent caregivers.
Outpatient mental
Any outpatient mental health subspecialist
health service use
service (i.e., mental health center,
psychologist, psychiatrist, social worker, or
psychiatric nurse) for an emotional,
behavioral, learning, attentional, or
substance use problem. Referent time
period was over the 3 years of the study for
temporary caregivers and lifetime for
permanent caregivers.
Restrictive care use Any service in a restrictive setting (i.e.,
therapeutic nursery, day treatment, group
home, residential care, inpatient). Referent
time period was over the 3 years of the
study for temporary caregivers and lifetime
for permanent caregivers.

NA

1

Case records

NA
Modified Maltreatment
Classification Scale

1
1

Case records
Case records

Child Behavior Checklist
(CBCL) Youth Self
report (YSR)

1

Caregiver report;
youth report ages
11 years

NA

1

Caregiver report

Child and Adolescent
Services Assessment
(Ascher et al. 1996)

1, 2, 3, 4

Caregiver report

Child and Adolescent
Services Assessment
(Ascher et al. 1996)

1, 2, 3, 4

Caregiver report

Child and Adolescent
Services Assessment
(Ascher et al. 1996)

1, 2, 3, 4

Caregiver report

Variables
Outcomes
Medication use

Medication use
group
Independent variables
Child placement

Description

Source
Caregiver

Derived for this
study

Abbreviations: NSCAW ¼ National Survey of Child and Adolescent Well-Being; NA ¼ not applicable; CBCL ¼ Child Behavior Checklist;
YSR ¼ Youth Self-Report.

regressions were run and demonstrated similar results; for this research, we chose to display the regression models using separate
logistic regressions for ease of interpretation by the reader. Because
medication use group demonstrated a nonlinear relationship with
age, we chose to transform age into a categorical variable, with
three groupings: Children ages 2–5, ages 6–11, and ages 12 and
older. Because the models were tolerant of the inclusion of the three
service use variables included as control variables, these variables
were maintained in the model. Note that numbers and percentages

reported in all tables do not total 100% because the reported percentages are weighted to account for the sampling design.
Results
Sample characteristics
Characteristics of the sample are shown in Table 2. Approximately 10% of youths were in out-of-home care at wave 1; the other
90% were living with a parent or informally with kin. About half
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Table 2. Characteristics of Youths Aged 2 or More in the NSCAW Study by Medication-Use
Groupa,b: Age 2 (n ¼ 2,521)

Independent variables

Increasing
medication use n ¼ 148

High medication
use n ¼ 316

n
% (se)
n
Child’s placement at wave 1**
In home
82
77.7 (7.1)
197
Out of home
66
22.3 (7.1)
119
Child’s age***
2–5
36
19.8 (7.4)
17
6–11
82
62.2 (7.5)
184
12þ
30
18.0 (4.9)
115
Child’s gender***
Male
97
75.1 (7.0)
198
Female
51
24.9 (7.0)
118
Child’s race=ethnicity***
African American
39
16.5 (5.0)
70
Caucasian
72
66.6 (7.0)
196
Hispanic
28
11.0 (3.8)
35
Other
9
5.9 (2.7)
15
Maltreatment history
Physical abuse*
Yes
53
51.9 (8.1)
117
No
89
48.1 (8.1)
173
Sexual abuse
Yes
25
8.5 (3.0)
56
No
117
91.5 (3.0)
234
Neglect*
Yes
90
58.6 (8.4)
144
No
52
41.4 (8.4)
146
Abandonment
Yes
10
3.2 (1.2)
14
No
132
96.8 (1.2)
276
CBCL=YSR total=externalizing=internalizing score at wave 1***
<64
44
26.7 (7.2)
57
64
104
73.3 (7.2)
259
Child’s insurance status at wave 1*
Medicaid
116
72.2 (7.8)
255
Private=Champus
20
22.2 (7.9)
51
No insurance
12
5.6 (2.6)
10
Any restrictive care***
Yes
80
54.3 (8.0)
188
No
68
(45.7) (8.0)
128
Any outpatient specialty mental health service***
Yes
135
89.9 (4.1)
294
No
13
10.1 (4.1)
22
Any general medical services***
Yes
111
84.1 (4.1)
257
No
37
15.9 (4.7)
59
National estimates (n, mean [se])
52519
3.9 (0.6)
156747

% (se)

Low medication
use n ¼ 2,057
n

% (se)

Total
N ¼ 2,521
n

(%)

82.6 (3.3)
17.4 (3.3)

1615
442

91.3 (1.0)
8.7 (1.0)

1894
627

89.7
10.3

8.9 (2.9)
57.0 (6.2)
34.1 (5.4)

721
902
434

34.6 (2.0)
46.5 (2.3)
18.9 (1.6)

774
1168
579

31.0
48.4
20.6

67.2 (4.4)
32.8 (4.4)

880
1177

43.2 (2.2)
56.8 (2.2)

1175
1346

47.3
52.7

31.0
43.3
19.2
6.5

(3.0)
(4.1)
(3.7)
(1.0)

745
1184
419
170

28.5
47.0
18.6
6.0

14.3
67.0
16.2
2.6

(3.4)
(5.8)
(5.2)
(1.1)

636
916
356
146

48.0 (4.9)
52.0 (4.9)

593
1338

32.7 (2.0)
67.3 (2.0)

763
1600

35.2
64.8

13.2 (3.2)
86.8 (3.2)

356
1575

13.7 (2.0)
86.3 (2.0)

437
1926

13.5
86.5

39.5 (5.2)
60.5 (5.2)

1141
790

56.9 (2.4)
43.1 (2.4)

1375
988

55.0
45.0

4.2 (2.3)
95.8 (2.3)

80
1851

2.2 (0.7)
97.8 (0.7)

104
2259

2.4
97.6

19.4 (4.8)
80.6 (4.8)

1241
814

62.4 (2.1)
37.6 (2.1)

1342
1177

56.0 (2.2)
44.0 (2.0)

70.0 (5.6)
25.7 (5.0)
4.3 (2.2)

1369
471
207

61.5 (2.5)
27.1 (2.0)
11.4 (1.5)

1740
542
229

62.9
26.7
10.4

48.5 (5.3)
51.5 (5.3)

216
1841

7.7 (0.8)
92.3 (0.8)

484
2037

14.2
85.8

91.3 (2.9)
8.7 (2.9)

841
1216

33.1 (2.7)
66.9 (2.7)

1270
1251

42.1
57.9

82.5 (4.1)
17.5 (4.1)
11.6 (1.2)

357
1700
1142905

17.0 (1.5)
83.0 (1.5)
84.5 (0.3)

725
1796
1352170

27.2
72.8

a

See Table 1 for complete description of each variable.
Note all percents are weighted to account for the study sampling plan.
*Significant at p < 0.05. **Significant at p < 0.01. ***Significant at p < 0.001.
Abbreviations: NSCAW ¼ National Survey of Child and Adolescent Well-Being; se ¼ standard error; CBCL ¼ Child Behavior Checklist; YSR ¼ Youth
Self-Report.
b

(48%) of the sample were aged 6–11 years, with one third 2–5 years
of age (31%) and the rest 12 years or greater (21%). The proportion
of males and females was equivalent. Almost half (47%) of the
sample was Caucasian. Over half (55%) reported a history of neglect, and more than one third (35%) reported physical abuse.
About 44% of youths had Total, Internalizing, or Externalizing
scores on the CBCL or YSR 64. About two thirds (63%) endorsed
having Medicaid insurance coverage. About one quarter (27%)

reported seeing a general medical provider physician, 42% had
seen an outpatient mental health specialist, and 14% had spent time
in restrictive care.
At wave 1, 13% of children had used a medication for emotional, behavioral, learning, attentional, or substance abuse problems; this increased to 16% by wave 4. Overall, 22% reported
using medication at one or more of the four study waves (data not
shown).
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Three groups derived by latent class analysis
As is recommended, we tested multiple solutions including two-,
three-, and four-group models. Indicators of good model fit in GMM
include a lower relative sample size-adjusted Bayesian information
criterion (SBIC) and a higher relative Entropy (values greater than
0.90), a summary number reflecting the quality of classification of
individuals into groups based on their posterior probabilities of
group membership for each group. We also considered utility of the
classification solution in practice (e.g., lack of overlap among
groups, large enough proportion of individuals within groups).
The three-group solution demonstrated the best fit based on the
criteria noted above (SBIC ¼ 7345.883; Entropy ¼ 0. 97), and the
groups were identified as: (1) Low users, those who reported limited or
no medication use over time; (2) increasing users, those who initiate
medication use over time following an investigation; and (3) high
users, those who enter the system using medications or start within a
close time frame to the initial CW=CPS investigation and consistently
report use over time. The majority of youths (85%, n ¼ 2057) were in
the low-use group, 4% (n ¼ 148) were in the increasing-use group, and
12% (n ¼ 316) were in the high-use group and endorsed medication
use across most and=or all of the 3 years of the study (see Fig. 1).
Characteristics of medication use groups
Table 2 demonstrates bivariate relationships between independent variables and the three identified groups. Placement in
out-of-home care at wave 1 was more commonly seen in the increasing-use group (w2 ¼ 5.13, degrees of freedom [df ] ¼ 2,
n ¼ 2,521, p ¼0.0079). Males were more likely than females to be
in the high- or increasing-use groups (w2 ¼ 1,445, df ¼ 2, n ¼ 2,521,
p ¼ 0.0000). Caucasians were more likely to be increasing- or highuse group members; conversely, African Americans were more
likely to be in the low-use group (w2 ¼ 5.48, df ¼ 6, n ¼ 2,518,
p ¼ 0.0001). The majority of 2 to 5 year olds were in the low-use
group. Preschoolers tended to be in the low and increasing-use

group, and youths 12 and up more likely to be in the high-use group
(w2 ¼ 13.50, df ¼ 4, n ¼ 2,521, p ¼ 0.0000). Youths with a history
of physical abuse were more likely to be in the increasing- or highuse groups (w2 ¼ 4.19, df ¼ 2, n ¼ 2,363, p ¼ 0.0185). Youths with
a history of neglect were more likely to be in the increasing- or lowuse groups (w2 ¼ 3.93, df ¼ 2, n ¼ 2,363, p ¼ 0.0234). Children
without insurance were more likely to be low users (w2 ¼ 2.60,
df ¼ 4, n ¼ 2,511, p ¼ 0.042). Children with any general medical
(w2 ¼ 42.41, df ¼ 2, n ¼ 2,521, p ¼ 0.0000), outpatient mental
health specialist use (w2 ¼ 40.36, df ¼ 2, n ¼ 2,521, p ¼ 0.0000), or
restrictive care (w2 ¼ 17.24, df ¼ 2, n ¼ 2,521, p ¼ 0.0000) were
more likely to be in the increasing- or high-use groups.
Predictors of group membership
Table 3 represents the logistic regression models delineating the
odds ratio for medication use by group for each independent variable examined in the model, controlling for all other variables. The
referent group for both logistic regression models was the low-use
group.
In the multivariate logistic regression model comparing the
increasing- and low-use groups (see Table 3), several variables did
differentiate the two groups. Specifically, males were 4.16 times as
likely as females to be in the increasing-use group (95% confidence
interval [CI], 2.16, 8.00). Age was significant for the overall
comparison ( p ¼ 0.02), but this was only apparent in the odds ratios
and confidence intervals when the age range 6–11 was used as the
reference group. Specifically, youths ages 12 and older were 0.35
times as likely to be in the increasing-use compared to youths ages
6–11 years (data not shown in table; 95% CI, 0.16, 0.76); no relationship was noted in comparison to the preschool age group.
Youths with a history of physical abuse were 2.82 times as likely as
youths without a history of physical abuse to be in the increasinguse group (95% CI, 1.37, 5.79). Use of general medical services
(odds ratio [OR], 6.93; 95% CI, 2.81, 17.06), outpatient specialty

100%
90%
80%
70%

Weighted
Proportion of 60%
Youth Using
Medication
50%
Within Group
40%
Increasing medication use (n=148, 4%)

30%

High medication use (n=316, 12%)
Low medication use (n=2057, 85%)

20%
10%
0%
Wave 1

Wave 2

Wave 3

Wave 4

Study Wave

FIG. 1.

Weighted proportion of youths using medication in latent medication groups at each study wave (n ¼ 2,521).
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Table 3. Logistic Regression Analysis: Increasing Medication-Use Group Compared to Low-Use Group (n ¼ 2,060)
Independent variables

Increasing medication use OR (95% CI)

Child’s placement in out-of-home care at wave 1 (in-home ¼ reference)
Child’s age (years)*
2–5
6–11
12þ
Child’s gender-male (female ¼ reference)***
Child’s race=ethnicity
African American
Hispanic
Other
Maltreatment history (no ¼ reference for each type of maltreatment)
Physical abuse**
Sexual abuse
Neglect
Abandonment
CBCL=YSR total=externalizing=internalizing score at wave 1 64 (<64 ¼ reference)
Child’s insurance
Medicaid
Private=Champus
No insurance
Any general medical services (no ¼ reference)***
Any outpatient specialty mental health (no ¼ reference)***
Any restrictive care (no ¼ reference)***

1.56 (0.75, 3.27)
1.00
2.10 (0.89, 4.95)
0.72 (0.26, 2.01)
4.16 (2.16, 8.00)
0.54 (0.23, 1.28)
0.46 (0.17, 1.25)
0.75 (0.14, 4.21)
2.82
1.18
1.61
0.60
2.01

(1.37,
(0.42,
(0.77,
(0.18,
(0.92,

5.79)
3.28)
3.38)
2.03)
4.38)

0.92 (0.20,
0.78 (0.17,
1.00
6.93 (2.81,
4.16 (1.44,
6.12 (2.71,

4.22)
3.67)
17.06)
12.04)
13.82)

*Significant at p < 0.05.
**Significant at p < 0.01.
***Significant at p < 0.001.
Abbreviations: OR ¼ Odds ratio; CI ¼ confidence interval; CBCL ¼ Child Behavior Checklist; YSR ¼ Youth Self-Report.

mental health services (OR, 4.16; 95% CI, 1.44, 12.04), and restricted care (OR, 6.12; 95% CI, 2.71, 13.82) were also strongly
associated with psychotropic medication use.
In the multivariate logistic regression model comparing the
high- and low-use groups (see Table 4), males were more likely to
be in the high-use group compared to females (OR, 2.86; 95% CI,
1.54, 5.30). Age also was associated with group membership;
youths ages 6–11 years and ages 12þ years were more likely to be
in the high-use group compared to youths ages 2–5 years (OR, 4.22;
95% CI, 1.72, 10.32; and OR, 3.10; 95% CI, 1.17, 8.19, respectively). Unlike the previous model, race=ethnicity was associated
with group membership; African-American youths were 0.30 times
as likely to be in the high-use group compared to Caucasians (95%
CI, 0.14, 0.64). Behavioral status, as measured by a Total, Internalizing, or Externalizing Score 64 on the CBCL and=or YSR,
was also associated with being in the high-use group (OR, 2.70,
1.27, 5.75). Use of general medical services (OR, 8.33; 95% CI,
4.33, 16.04), outpatient specialty mental health services (OR, 7.20;
95% CI, 2.34, 22.14), and restricted care (OR, 3.54; 95% CI, 1.84,
6.82) were also positively associated with membership in the highuse group compared to the low-use group.
Last, we compared the increasing-use group to the high-use
group (see Table 5). On multivariate logistic regression modeling,
only three variables were significant. Youths with a history of
physical abuse were more likely to be in the increasing-use group
compared to the high-use group (OR, 2.86; 95% CI, 1.15, 7.10), and
those with a history of neglect were similarly more likely to be in
the increasing-use group (OR, 4.48; 95% CI, 1.70, 11.78). Youths
who had used any restrictive care were also more likely to be
represented in the increasing-use group (OR, 2.62; 94% CI, 1.22,

5.61). Although age as an overall variable was marginally associated with group membership ( p ¼ 0.08), youths ages 12 years and
older were less likely than youths ages 2–5 years (OR, 0.16; 95%
CI, 0.03, 0.81) to be in the increasing-use group.
Discussion
In this paper, we describe for the first time longitudinal patterns
of rates of psychotropic medication use among a nationally representative sample of youths involved with CW=CPS. Reported
rates of medication use were 22% across the 3-year period, suggesting that one fifth of all youths aged 2–16 years undergoing an
investigation report are likely to be taking psychotropic medications at some time within 3 years of an investigation. We found
three distinct medication use groups: (1) Low users, those who
reported limited or no medication use over time; (2) increasing
users, those who initiate medication use over time following an
investigation; and (3) high users, those who enter the system using
medications or start within a close time frame to the initial
CW=CPS investigation and consistently report use over time. The
majority of youths were in the low-use group; contrary to our
hypotheses, only a small proportion of youths (4%) were in the
increasing-use group. This suggests that only a limited proportion
of children begin medications following investigation. When
weighted back to the entire U.S. population of children undergoing
an investigation over a 15-month period from October, 1999, to
December, 2000, 1,142,905 children would most likely be classified as low users, 156,747 children as high users, and 52,519
children as increasing users over the 3-year follow-up period (see
Table 2).
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Table 4. Logistic Regression Analysis: High-Medication-Use Group Compared to Low-Use Group (n ¼ 2,208)
Independent variables

High medication use OR (95 % CI)

Child’s placement in out-of-home care at wave 1 (in-home ¼ reference)
Child’s age (years)**
2–5
6–11**
12þ*
Child’s gender-male (female ¼ reference)**
Child’s race=ethnicity (Caucasian ¼ reference)*
African American**
Hispanic
Other
Maltreatment history (no ¼ reference for each type of maltreatment)
Physical abuse
Sexual abuse
Neglect
Abandonment
CBCL=YSR total=externalizing=internalizing score at wave 1 64 (<64 ¼ reference)*
Child’s insurance (no ¼ reference)
Medicaid
Private=Champus
Any general medical services (no ¼ reference)***
Any outpatient specialty mental health (no ¼ reference)***
Any restrictive care (no ¼ reference)***

1.42 (0.68,2.58)
1.00
4.22 (1.72, 10.32)
3.10 (1.17, 8.19)
2.86 (1.54, 5.30)
0.30 (0.14, 0.64)
0.99 (0.30, 3.27)
0.46 (0.14, 1.50)
1.32
0.77
0.67
3.33
2.70

(0.68, 2.57)
(031, 1.89)
(0.34, 1.33)
(0.34, 32.80)
(1.27, 5.75)

2.59
2.89
8.33
7.20
3.54

(0.78,
(0.80,
(4.33,
(2.34,
(1.84,

8.57)
10.36)
16.04)
22.14)
6.82)

*Significant at p < 0.05.
**Significant at p < 0.01.
***Significant at p < 0.001.
Abbreviations: OR ¼ Odds ratio; CI ¼ confidence interval; CBCL ¼ Child Behavior Checklist; YSR ¼ Youth Self-Report.

Our results indicate that there is considerable heterogeneity in
medication use trajectories following entry into child welfare,
even among youths demonstrating behavioral symptoms as measured on the CBCL=YSR. Only a limited number of youths start
medication after entry; a larger proportion of youths enter
CW=CPS with a history of medication use and generally maintain
that use over time. However, the majority of youths report limited
to no use of medication. Whether these rates of use reflect under
use, appropriate use, or over use of medications cannot be determined using the NSCAW data. It is striking, though, that only one
quarter (27%) reported seeing a general medical provider physician and less than half had seen an outpatient mental health
specialist (42%). This suggests that youths undergoing investigation are not well connected to health and mental health service
systems despite the fact that 44% had rates of need in the clinical
range on the CBCL, a high cut point indicating serious emotional
needs.
We next examined variables associated with group membership
in a multivariate model. Male gender was positively associated
with the increasing- and high-use groups in comparison to the lowuse group, but not in the comparison between the increasing-use
and high-use groups. Age displayed a complex relationship with
group membership. Youths ages 6–11 years and 12 years and
greater were more likely to be in the high-use group compared to
youths ages 2–5 years (reference group, low use). Youths ages 12
years and greater were less likely to be in the increasing-use group
compared to youths ages 6–11 years (reference group, low use) and
to preschool-age youths (reference group, high use). The use of
psychotropic medication among preschool and latency age children
in the increasing-use group is particularly worrisome, given
growing concerns regarding the trend in off-label use of psycho-

tropic medications among young children in the general population
(Vitiello 2001). Abuse similarly showed a complex relationship
with group membership. For youths in the increasing-use group, a
history of physical abuse but not behavioral problems was associated with group membership, when compared to low users. Conversely, behavioral status but not physical abuse was found to be
associated with high users compared to low users. Abuse type
(physical and neglect) differentiated between the increasinguse and high-use groups. In addition, African-American youths
were less likely to be in the high-use group compared to the low-use
group. Placement, as defined as out-of-home versus in-home at
wave 1, was not associated with medication use group but time
spent in restrictive care was associated with both the increasing-use
and high-use groups.
Many of these variables have previously been linked to medication
use, specifically older age (Zima et al. 1999b; dosReis et al. 2005;
Raghavan et al. 2005; Ferguson et al. 2006), male gender (dosReis
et al. 2005; Raghavan et al. 2005; Ferguson et al. 2006), Caucasian
race=ethnicity (Zima et al. 1999b; McMillen et al. 2004; Raghavan
et al. 2005; Ferguson et al. 2006), a history of physical abuse (Raghavan et al. 2005), public insurance (Raghavan et al. 2005), foster
care placement (dosReis et al. 2005), and placement in group homes
(Zima et al. 1999b; Breland-Noble et al. 2004). African-American
and Latino ethnicities, as well as history of neglect, have been associated with decreased medication use in previous analyses of the
NSCAW data examining use at wave 2 (Raghavan et al. 2005). The
variation in the factors influencing medication use among the three
groups, even when controlling for behavioral status, reiterates findings from previous studies—that medication use among children in
CW=CPS is not solely driven by clinical symptomatology, at least as
measured by the CBCL and YSR.
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Table 5. Logistic Regression Analysis: Increasing Medication Use Group Compared to High-Use Group (n ¼ 432)
Independent variables

Increasing medication use OR (95% CI)

Child’s placement in out-of-home care at wave 1 (in-home ¼ reference)
Child’s age (years)
2–5
6–11
12þ*
Child’s gender-male (female ¼ reference)
Child’s race=ethnicity
African American
Hispanic
Other
Maltreatment history (no ¼ reference for each type of maltreatment)
Physical abuse*
Sexual abuse
Neglect**
Abandonment
CBCL=YSR total=externalizing=internalizing score at wave 1 64 (<64 ¼ reference)
Child’s insurance
Medicaid
Private=Champus
No insurance
Any general medical services (no ¼ reference)
Any outpatient specialty mental health (no ¼ reference)
Any restrictive care (no ¼ reference)*

0.89 (0.43, 1.86)
1.00
0.24 (0.06, 1.03)
0.16 (0.03, 0.81)
1.69 (0.71, 4.00)
1.67 (0.64, 4.36)
0.58 (0.16, 2.11)
4.42 (0.87, 22.37)
2.86
1.70
4.48
0.45
0.46

(1.15,
(0.46,
(1.70,
(0.10,
(0.18,

0.32 (0.07,
0.25 (0.05,
1.00
0.75 (0.25,
0.83 (0.24,
2.62 (1.22,

7.10)
6.19)
11.78)
2.05)
1.19)
1.56)
1.31)
2.23)
2.87)
5.61)

*Significant at p < 0.05.
**Significant at p < 0.01.
Abbreviations: OR ¼ Odds ratio; CI ¼ confidence interval; CBCL ¼ Child Behavior Checklist; YSR ¼ Youth Self-Report.

However, the novel findings in this research suggest that youths
vary in their trajectories of use and that these trajectories appear to
be associated with different independent variables. This research
suggests a number of future research questions to further disentangle medication use patterns among youths in child welfare, including: (1) The interplay between age, race=ethnicity, abuse
history, and behavioral status in predicting medication use, and (2)
medication use and its temporal relation to episode(s) of restricted
care. Last, these different patterns of medication use suggest social
workers, medical, and mental health clinicians are using some
mechanisms for classifying the mental health needs of youths as
they enter the child welfare system. How these decisions are made
and what modalities (i.e., psychotherapeutic as well as pharmacological) are recommended and then used deserves further exploration.
Limitations
Some limitations of this study should be noted. Specifically,
NSCAW does not contain data to examine numbers or types of
medication used or patterns of episodic versus continuous use between waves. In addition, NSCAW did not garner clinical diagnoses, either through a diagnostic interview or clinician-generated
administrative data, and thus we cannot comment on the quality of
care received. The proportion of children in out-of-home care
compared to in-home limited our ability to examine medication use
among children in different types of out-of-home care at wave 1.
Also, the different referent time periods for general medical and
subspecialty services for temporary and nonpermanent caregivers
makes comparisons across groups for these services incomplete.
Last, whether these rates of use reflect overutilization of psychotropic medications cannot be determined using this large data

survey set and will require more complete measures of clinical need
as well as controlling for receipt and intensity of psychotherapeutic
modalities.
Conclusions
This study is the first to examine trajectories of medication use
longitudinally in a nationally representative probability sample of
youths in CW=CPS, thus avoiding sampling biases inherent in
cross-sectional and regional studies. The findings suggest that the
majority of youths undergoing an investigation have limited to no
use of psychotropic medication over time. However, there is a
unique subpopulation of youths who are consistently on medication
as well as a smaller group of youths who begin medication
following investigation. Understanding how clinical need, race=
ethnicity, gender, age, maltreatment history, and service use drive
variations in medication use over time will be critical for developing interventions to counter both under- and overprescribing of
medications to youths in CW=CPS and to assure quality mental
health care for these vulnerable youths.
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